| |
|
|
| |
|
|
| |
David Leitenberg, MD, PhD - Center for Cancer and Immunology Research - Children's Research Institute - Children's National Medical Center
David Leitenberg, MD, PhD
 |
Children's National
Medical Center
Faculty, Children's Research Institute (CRI), Center
for Cancer and Immunology Research (CCIR)
George Washington University
School
of Medicine and Health Sciences
Associate
Professor, Microbiology, Immunology and Tropical Medicine; Pediatrics;
Pathology
|
Contact Information
Children's National
Medical Center
Center
for Cancer and Immunology Research (CCIR)
111 Michigan
Avenue, NW
Washington,
DC 20010-2970
202-476-5000
Education & Training
| Institution &
Location |
Degree |
Year(s) |
Field of Study |
University of Vermont, Burlington, VT
|
BA
|
1983 |
Zoology
|
University
of Iowa, Iowa City, IA
|
MD
|
1990 |
Medicine
|
| University
of Iowa, Iowa City, IA
|
PhD
|
1990
|
Immunology
|
| Yale-New Haven Hospital, New Haven, CT
|
Resident
|
1990 -
1993
|
Clinical Pathology
|
Yale
University, New Haven, CT
|
Fellow
|
1993
-
1995
|
Immunobiology
|
Research Interests
Dr. Leitenberg serves
as Director of the Immunology Laboratory in the Division of
Laboratory Medicine at Children’s National Medical Center. His
expertise is in the flow cytometric diagnosis of immunodeficiency
syndromes and hematologic neoplasms.
Dr. Leitenberg's research is focuses on the regulation of cell fate
decisions in T lymphocytes. Understanding the factors that
regulate lymphocyte survival and development into functionally distinct
subsets is critical for the rational design of therapeutic strategies
to enhance protective immune responses to infectious diseases and
tumors, as well as to ameliorate harmful immune responses in autoimmune
and inflammatory disorders.
Projects in Leitenberg's laboratory are broadly based on the hypothesis
that signal transduction events that regulate cell fate decisions are
developmentally regulated and modulated by the tissue microenvironment.
His current projects involve the roles of the CD45 protein tyrosine
phosphatase and the CD4-associated src family tyrosine kinase, Lck, in
selectively regulating cell development and survival and in regulating
host-immune response in vivo.
Clinical Interests
Click here for more information about
this doctor's clinical
practice, including how to make an appointment.
Publications
View a partial list of publications
for David Leitenberg
through the National Library of Medicine's PubMed online
database.
Back to Top
|
|
|
|
|
|
